Acus Laboratories


Collaborative research at the Max Planck Institute for Biology of Ageing in Cologne, Germany, and the Institute for Molecular Biotechnology of Austrian Academy of Sciences in Vienna, Austria, laid the foundation for the spin-out of Acus, based in Cologne, Germany. In 2018 Acus was brought to life by Josef Penninger, Ulrich Elling, Martin Denzel and Moritz Horn, who are now Scientific Team members and shareholders of JLP Health. All of them were shareholders of Acus completed by the Max Planck Institute as minority shareholder. JLP Health GmbH took over Acus Laboratories via a share swap in early 2019.